Argus maintains AstraZeneca ADR at Buy

  • Investing.com
Argus maintains AstraZeneca ADR at Buy

An Argus analyst maintained AstraZeneca ADR (NASDAQ: AZN) at Buy and a price target of $85.00 from a prior price target of $75.00.

Prior to this rating, AstraZeneca ADR had 6 buy ratings, 2 hold ratings, and 0 sell ratings.

For consensus analyst estimates and price targets on AstraZeneca ADR, click here. For more news on AstraZeneca ADR, click here.

AstraZeneca ADR's stock price closed at $73.76. They are up 14.21% in the last month and up 7.52% in the last 12 months.

According to Investing Pro, AstraZeneca ADR's fair value is $78.89, an upside of 6.96%. AstraZeneca ADR's fair value comes with a low degree of uncertainty, according to InvestingPro.

Check out AstraZeneca ADR's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100